Literature DB >> 1149556

Melioidosis: recrudescence associated with bronchogenic carcinoma twenty-six years following initial geographic exposure.

E E Mays, E A Ricketts.   

Abstract

Melioidosis was diagnosed in association with lung cancer in a World War 2 veteran 26 years after geographic exposure. The case history illustrates the prolonged latency, difficult diagnosis, and resistance to therapy of chronic melioidosis. Implications are that chronic forms of the disease will continue to surface in veterans of Southeast Asian conflicts for decades.

Entities:  

Mesh:

Year:  1975        PMID: 1149556     DOI: 10.1378/chest.68.2.261

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  54 in total

1.  A Burkholderia pseudomallei type III secreted protein, BopE, facilitates bacterial invasion of epithelial cells and exhibits guanine nucleotide exchange factor activity.

Authors:  Mark P Stevens; Andrea Friebel; Lowrie A Taylor; Michael W Wood; Philip J Brown; Wolf-Dietrich Hardt; Edouard E Galyov
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

2.  Genomic plasticity of the causative agent of melioidosis, Burkholderia pseudomallei.

Authors:  Matthew T G Holden; Richard W Titball; Sharon J Peacock; Ana M Cerdeño-Tárraga; Timothy Atkins; Lisa C Crossman; Tyrone Pitt; Carol Churcher; Karen Mungall; Stephen D Bentley; Mohammed Sebaihia; Nicholas R Thomson; Nathalie Bason; Ifor R Beacham; Karen Brooks; Katherine A Brown; Nat F Brown; Greg L Challis; Inna Cherevach; Tracy Chillingworth; Ann Cronin; Ben Crossett; Paul Davis; David DeShazer; Theresa Feltwell; Audrey Fraser; Zahra Hance; Heidi Hauser; Simon Holroyd; Kay Jagels; Karen E Keith; Mark Maddison; Sharon Moule; Claire Price; Michael A Quail; Ester Rabbinowitsch; Kim Rutherford; Mandy Sanders; Mark Simmonds; Sirirurg Songsivilai; Kim Stevens; Sarinna Tumapa; Monkgol Vesaratchavest; Sally Whitehead; Corin Yeats; Bart G Barrell; Petra C F Oyston; Julian Parkhill
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-17       Impact factor: 11.205

3.  Biological relevance of colony morphology and phenotypic switching by Burkholderia pseudomallei.

Authors:  Narisara Chantratita; Vanaporn Wuthiekanun; Khaemaporn Boonbumrung; Rachaneeporn Tiyawisutsri; Mongkol Vesaratchavest; Direk Limmathurotsakul; Wirongrong Chierakul; Surasakdi Wongratanacheewin; Sasithorn Pukritiyakamee; Nicholas J White; Nicholas P J Day; Sharon J Peacock
Journal:  J Bacteriol       Date:  2006-11-17       Impact factor: 3.490

4.  Role of reactive nitrogen and oxygen intermediates in gamma interferon-stimulated murine macrophage bactericidal activity against Burkholderia pseudomallei.

Authors:  K Miyagi; K Kawakami; A Saito
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

5.  Melioidosis in a patient from Bangladesh.

Authors:  C C Kibbler; C M Roberts; G L Ridgway; S G Spiro
Journal:  Postgrad Med J       Date:  1991-08       Impact factor: 2.401

6.  Outcomes of patients with melioidosis treated with cotrimoxazole alone for eradication therapy.

Authors:  Sarunyou Chusri; Thanaporn Hortiwakul; Boonsri Charoenmak; Khachornsakdi Silpapojakul
Journal:  Am J Trop Med Hyg       Date:  2012-10-01       Impact factor: 2.345

7.  Relationships among Pseudomonas pseudomallei isolates from patients with recurrent melioidosis.

Authors:  P M Desmarchelier; D A Dance; W Chaowagul; Y Suputtamongkol; N J White; T L Pitt
Journal:  J Clin Microbiol       Date:  1993-06       Impact factor: 5.948

8.  RAPD analysis of isolates of Burkholderia pseudomallei from patients with recurrent melioidosis.

Authors:  A Haase; A Melder; H Smith-Vaughan; D Kemp; B Currie
Journal:  Epidemiol Infect       Date:  1995-08       Impact factor: 2.451

9.  Intracellular survival of Burkholderia pseudomallei.

Authors:  A L Jones; T J Beveridge; D E Woods
Journal:  Infect Immun       Date:  1996-03       Impact factor: 3.441

Review 10.  Strategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Sara K Bondi; Joanna B Goldberg
Journal:  Expert Rev Vaccines       Date:  2008-11       Impact factor: 5.217

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.